Nikko Asset Management Americas, Inc. - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$9,151,934
-65.8%
907,930
-29.6%
0.13%
-61.4%
Q3 2022$26,744,000
-8.6%
1,288,858
+1.4%
0.34%
-5.3%
Q2 2022$29,263,000
-37.0%
1,270,565
+0.6%
0.36%
+5.9%
Q1 2022$46,473,000
-35.6%
1,262,866
+1.6%
0.34%
-10.3%
Q4 2021$72,209,000
-0.1%
1,242,843
-0.3%
0.38%
+22.6%
Q3 2021$72,301,000
-17.2%
1,246,570
+21.6%
0.31%
-9.4%
Q2 2021$87,313,000
+88.6%
1,025,519
+82.6%
0.34%
+50.7%
Q1 2021$46,304,000
-5.3%
561,595
+4.5%
0.23%
-18.3%
Q4 2020$48,890,000
+152.8%
537,664
+10.1%
0.28%
+62.6%
Q3 2020$19,341,000
+13.2%
488,399
-7.4%
0.17%
-23.7%
Q2 2020$17,085,000
-58.5%
527,311
-71.5%
0.22%
-42.0%
Q1 2020$41,134,000
+156.4%
1,852,018
+125.9%
0.39%
+52.6%
Q4 2019$16,044,000
+22.9%
819,810
-2.5%
0.25%
+9.1%
Q3 2019$13,052,000
+26.4%
840,430
+65.2%
0.23%
+14.3%
Q2 2019$10,329,000508,8410.20%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders